propafenone has been researched along with Apoplexy in 3 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"propafenone." | 1.91 | Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants. ( Chang, SH; Chen, SW; Huang, CH; Huang, YC; Huang, YT; Hung, KC; Kuo, CF; Tu, HT; Wang, CL; Wu, VC, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Wu, VC | 1 |
Wang, CL | 1 |
Huang, YC | 1 |
Tu, HT | 1 |
Huang, YT | 1 |
Huang, CH | 1 |
Chen, SW | 1 |
Kuo, CF | 1 |
Hung, KC | 1 |
Chang, SH | 1 |
Lip, GY | 1 |
Fauchier, L | 1 |
Freedman, SB | 1 |
Van Gelder, I | 1 |
Natale, A | 1 |
Gianni, C | 1 |
Nattel, S | 1 |
Potpara, T | 1 |
Rienstra, M | 1 |
Tse, HF | 1 |
Lane, DA | 1 |
Kowey, PR | 1 |
Yan, GX | 1 |
Winkel, E | 1 |
Kao, W | 1 |
2 reviews available for propafenone and Apoplexy
Article | Year |
---|---|
Atrial fibrillation.
Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun | 2016 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablati | 2003 |
1 other study available for propafenone and Apoplexy
Article | Year |
---|---|
Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Brain | 2023 |